Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis

References

• Abou-Sleiman P, Hanna M, Wood N. (2006). Genetic association studies of complex neurological diseases. J Neurol Neurosurg Psychiatry, 77(12), 1302–1304.
   PubMed Web of Science ®Google Scholar
• Avolio C, Ruggieri M, Giuliani F, et al. (2003). Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes. J Neuroimmunology, 136(1), 46–53.
   PubMed Web of Science ®Google Scholar
• Beeghly-Fadiel A, Long J-R, Gao Y-T, et al. (2008). Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality. Cancer Res, 68(15), 6453–6459.
   PubMed Web of Science ®Google Scholar
• Benešová Y, Vašků A, Štourač P, et al. (2008). Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis. J Neuroimmunology, 205(1), 105–109.
   PubMed Web of Science ®Google Scholar
• da Silva Fernandes KS, Brum DG, Palei AC, et al. (2012). Functional MMP-9 polymorphisms modulate plasma MMP-9 levels in multiple sclerosis patients. J Neuroimmunology, 249(1), 56–59.
   PubMed Web of Science ®Google Scholar
• Demacq C, Vasconcellos VB, Marcaccini AM, et al. (2008). Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clin Chem Lab Med, 46(1), 57–63.
   PubMed Web of Science ®Google Scholar
• Etemadifar M, Sajjadi S, Nasr Z, et al. (2013). Epidemiology of multiple sclerosis in Iran: a systematic review. Eur Neurol, 70(5–6), 356–363.
   PubMed Web of Science ®Google Scholar
• Farrokhi M, Etemadifar M, Jafary Alavi MS, et al. (2015). TNF-alpha production by peripheral blood monocytes in multiple sclerosis patients and healthy controls. Immunol Invest, 44(6), 590–601.
   PubMed Web of Science ®Google Scholar
• Fernandes KS, Brum DG, Sandrim VC, et al. (2009). Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease. J Neuroimmunology, 214(1), 128–131.
   PubMed Web of Science ®Google Scholar
• Gai X, Zhang Z, Liang Y, et al. (2010). MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease. Clin. Chim. Acta, 411(9), 719–724.
   PubMed Web of Science ®Google Scholar
• Galboiz Y, Shapiro S, Lahat N, Miller A. (2002). Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-γ and-β: implications to multiple sclerosis. J Neuroimmunology, 131(1), 191–200.
   PubMed Web of Science ®Google Scholar
• Harbo HF, Gold R, Tintoré M. (2013). Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disorders, 6(4), 237–248.
   PubMed Web of Science ®Google Scholar
• Honardoost MA, Kiani-Esfahani A, Ghaedi K, et al. (2014). miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing–remitting multiple sclerosis. Gene, 544(2), 128–133.
   PubMed Web of Science ®Google Scholar
• Javaid MA, Abdallah M-N, Ahmed AS, Sheikh Z. (2013). Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview. Acta Neurol Belgica, 113(4), 381–390.
   PubMed Web of Science ®Google Scholar
• Jiang L, Bai X, Wang Y, Wei M. (2015). Association between CD24-P226-C/T polymorphism and multiple sclerosis: a meta-analysis. Immunol Invest, 44(4), 321–330.
   PubMed Web of Science ®Google Scholar
• Kallaur AP, Kaimen-Maciel DR, Morimoto HK, et al. (2011). Genetic polymorphisms associated with the development and clinical course of multiple sclerosis (review). Int J Mol Med, 28(4), 467–479.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. (1983). Rating neurologic impairment in multiple sclerosis an expanded disability status scale (EDSS). Neurology, 33(11), 1444–1444.
   PubMed Web of Science ®Google Scholar
• Lacchini R, Metzger IF, Luizon M, et al. (2010). Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence. DNA Cell Biol., 29(11), 649–655.
   PubMed Web of Science ®Google Scholar
• La Russa A, Cittadella R, De Marco EV, et al. (2010). Single nucleotide polymorphism in the MMP-9 gene is associated with susceptibility to develop multiple sclerosis in an Italian case-control study. J Neuroimmunology, 225(1), 175–179.
   PubMed Web of Science ®Google Scholar
• Liuzzi GM, Latronico T, Branà MT, et al. (2011). Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients. Neurochem Res, 36(3), 518–527.
   PubMed Web of Science ®Google Scholar
• Metzger IF, Luizon MR, Lacchini R, Tanus-Santos JE. (2012). Genetic variants in matrix metalloproteinase-9 gene modify metalloproteinase-9 levels in black subjects. DNA Cell Biol, 31(4), 504–510.
   PubMed Web of Science ®Google Scholar
• Mirowska-Guzel D, Gromadzka G, Czlonkowski A, Czlonkowska A (2009). Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population. J Neuroimmunology, 214(1), 113–117.
   PubMed Web of Science ®Google Scholar
• Nelissen I, Dubois B, Goris A, et al. (2002). Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis. J Neurol Sci, 200(1), 43–48.
   PubMed Web of Science ®Google Scholar
• Pravica V, Markovic M, Cupic M, et al. (2013). Multiple sclerosis: individualized disease susceptibility and therapy response. Biomarkers Med, 7(1), 59–71.
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Kazemian L, Malek-Khosravi S, et al. (2015). Matrix metalloproteinase-7 A-181G and its interaction with matrix metalloproteinase-9 C-1562T polymorphism in preeclamptic patients: association with malondialdehyde level and severe preeclampsia. Arch Gynecology Obstetrics, 291(1), 45–51.
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Mozafari H, Shahriari-Ahmadi A, et al. (2010). Deep venous thrombosis and thrombophilic mutations in western Iran: association with factor V Leiden. Blood Coagulation Fibrinolysis, 21(5), 385–388.
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Rahimi Z, Aghaei A, Vaisi-Raygani A. (2014). AT2R− 1332 G: A polymorphism and its interaction with AT1R 1166 A: C, ACE I/D and MMP-9− 1562 C: T polymorphisms: Risk factors for susceptibility to preeclampsia. Gene, 538(1), 176–181.
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Rahimi Z, Mohammadi F, et al. (2014). Association of matrix metalloproteinase-7A-181G variants with the risk of multiple sclerosis. Pers Med, 11(8), 727–733.
   Web of Science ®Google Scholar
• Rahimi Z, Rahimi Z, Shahsavandi MO, et al. (2013). MMP-9 (-1562 C: T) polymorphism as a biomarker of susceptibility to severe pre-eclampsia. Biomarkers Med, 7(1), 93–98.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. (2009). Matrix metalloproteinase-9 (MMP9)—a mediating enzyme in cardiovascular disease, cancer, and neuropsychiatric disorders. Cardiovas Psychiatry Neurol, 2009, 1–7.
   Google Scholar
• Saman-Nezhad B, Rezaee T, Bostani A, et al. (2013). Epidemiological characteristics of patients with multiple sclerosis in Kermanshah, Iran in 2012. J Mazandaran Univ Med Sci, 23(104), 97–101.
   Google Scholar
• Shajarian M, Alsahebfosoul F, Etemadifar M, et al. (2015). IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects. Immunol Invest, 44(1), 36–44.
   PubMed Web of Science ®Google Scholar
• Srivastava P, Gangwar, Kapoor R, Mittal RD. (2010). Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population. Dis. Markers, 29(1), 37–46.
   PubMed Web of Science ®Google Scholar
• Teunissen CE, Killestein J, Giovannoni G. (2007). Biomarker research in multiple sclerosis: addressing axonal damage and heterogeneity. Biomarker in Medicine, 1(1), 111–119.
   Google Scholar
• Yari K, Rahimi Z, Moradi MT. (2013). The MMP-2-735 C allele is a risk factor for susceptibility to breast cancer. Asian Pac J Cancer Prev: APJCP, 15(15), 6199–6203.
   Google Scholar
• Živković M, Djurić T, Dinčić E, et al. (2007). Matrix metalloproteinase-9-1562 C/T gene polymorphism in Serbian patients with multiple sclerosis. J Neuroimmunology, 189(1), 147–150.
   PubMed Web of Science ®Google Scholar